Trine Ollegaard Jensen

Trine Ollegaard Jensen

Auto-generated profile, based on publicly available information

Trine Ollegaard Jensen

Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2011 in Cancer
Verified
Journal Article
Open access
PDF file
TJTrine O. Jensen
Trine O. Jensen
HSHenrik Schmidt
Henrik Schmidt
HMHolger Jon Møller
Holger Jon Møller
FDFrede Donskov
Frede Donskov
MHMorten Høyer
Morten Høyer
TSTorben Steiniche
Torben Steiniche
BACKGROUND: Tumor cell and host immune cell interaction plays a key role in carcinogenesis. Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in cancer and believed to be an important mediator of tumor‐induced immunosuppression. This paper aims to describe the prognostic impact of neutrophil and dendritic cell infiltration in primary melanoma and the association of this infiltration with activated STAT3 (pSTAT3) in primary melanoma cells.METHODS: Formalin‐fixed, paraffin‐embedded primary melanomas from 186 stage‐I/II melanoma patients surgically resected from 1997 to 2000. Infiltrating neutrophils (CD66b), dendritic cells (CD123+ and DC‐LAMP+), T‐lymphocytes (CD8) and pSTAT3 melanoma cell expression were studied by immunohistochemistry and evaluated as present or absent. DC‐LAMP+ cell infiltration was evaluated as absent/few versus dense. Study endpoints: relapse‐free survival, melanoma‐specific, and overall survival.RESULTS: The median observation time was 12.2 years (range, 10.4‐14.2 years). Fifty‐one deaths were observed of which 38 (20%) were melanoma‐specific. In a multivariate Cox proportional hazards model including ulceration and melanoma thickness, neutrophil and CD123+ dendritic cell infiltration were independently associated with poor prognosis (CD66b: hazard ratio [HR] = 3.13; 95% confidence interval [CI], 1.43‐6.83; P = .004; CD123: HR = 2.45; 95% CI, 1.22‐4.92; P = .012). The association between melanoma cell pSTAT3 expression and immune infiltration (neutrophils and CD123+ cells) was strong. pSTAT3 expression, CD8 and DC‐LAMP infiltration were not independently associated with poor prognosis.CONCLUSIONS: Neutrophil infiltration and CD123+ dendritic cell infiltration in primary melanoma are independently associated with poor prognosis. Melanoma cell expression of pSTAT3 is strongly associated with the surrounding immune infiltrate. Cancer 2012;. © 2011 American Cancer Society.

1 December 2011 in Melanoma Research
Verified
Journal Article
Closed access
TJTrine Ollegaard Jensen
Trine Ollegaard Jensen
RRRikke Riber-Hansen
Rikke Riber-Hansen
HSHenrik Schmidt
Henrik Schmidt
SHStephen Jacques Hamilton-Dutoit
Stephen Jacques Hamilton-Dutoit
TSTorben Steiniche
Torben Steiniche
The importance of tumor immune response is ever more evident in melanoma carcinogenesis. One approach to explore the pathological mechanisms involved in such immune responses, and to analyze other tumor prognostic markers in melanoma, is to use tissue microarrays (TMAs). However, TMA technology remains to be adequately validated in this setting. Protein expression patterns in whole slides and TMA sections from 34 melanoma patients were compared for a number of inflammation and tumor cell markers using immunohistochemical stains against CD8 (lymphocytes), CD163 (macrophages), micropthalmia transcription factor, N-cadherin, melanoma cell-adhesion molecule, and c-kit protein (CD117). Using simplified versions of previously published grading systems, the agreement between TMA and whole slide sections ranged between 83 and 96%, and between 81 and 97% for inflammation and tumor cell markers, respectively. We conclude that TMA technology combined with simplified grading systems are appropriate for analyzing both inflammation and tumor cell markers in melanoma.